Skip to main content
. 2018 Mar 27;9(23):16533–16546. doi: 10.18632/oncotarget.24814

Figure 1. Comparison of growth inhibition of NSCLC cells by 4 different agents.

Figure 1

8 NSCLC cell lines were treated by gefitinib, cetuximab, afatinib, and dasatinib alone, respectively. Individual % of cell viability is the mean ± SD from at least three experiments.